Aditxt (ADTX) Stock Sinks 20% After-Hours: Here’s What’s Going On
Aditxt (ADTX) Stock Is Falling After Hours: What Is Going On?
Aditxt (ADTX) Stock Surges Nearly 17% After Hours: Here's Why
What's Going On With Aditxt Stock Wednesday?
Aditxt Unit Ignite Proteomics To Merge With A Strategic Counterparty At An Implied Equity Valuation Of ~$150M
Aditxt Unit Ignite Proteonomics Launches Prospective Oncology Registry, Enrolling Up To 10K Patients To Pair It CLIA-Certified Reverse Phase Protein Array Platform With Structured Clinical Outcomes
Aditxt Appoints Jeffrey M. Busch Interom CEO, Effective May 31
Aditxt Q1 EPS $(790.49) Up From $(198.07 thousand) YoY, Sales $12.159K Up From $1.018K YoY
Aditxt, Inc. (NASDAQ: ADTX) Announces 1-for-27 Reverse Stock Split Effective at the Open of Trading on May 18, 2026
Aditxt shares are trading lower. Its subsidiary Ignite Proteonomics was included in a study published in the journal npj Precision Oncology.
Dana-Farber Cancer Institute Study Demonstrates Predictive Value of Ignite Proteomics’ RPPA Platform for T-DXd (Enhertu®) Therapy in Metastatic Breast Cancer Patients
Aditxt's Ignite Proteomics Was Featured In NPJ Precision Oncology
Aditxt Subsidiary Ignite Proteomics Appoints Public Company Veteran Jeff Busch as Chief Executive Officer
Aditxt Acquires Ignite Proteomics to Address a Critical Challenge in Cancer Care: Optimizing Therapy Selection
Aditxt Acquires Ignite Proteomics In Transaction Providing 36K Shares Of Aditxt's Newly Designated Series A-2 Convertible Preferred Stock, Representing Aggregate Stated Value Of $36M
Trading Halt: Halt status updated at 8:55:00 AM ET: Quotation Resumption: News and Resumption Times
Trading Halt: Halted at 7:50:00 p.m. ET - Trading Halt: Halt News Pending
Aditxt, Inc. (NASDAQ: ADTX) Announces 1-for-8 Reverse Stock Split Effective at the Open of Trading on March 9, 2026
Aditxt Announces 1-For-8 Reverse Stock Split, Effective March 9
Sign up for free to unlock this feature.
Creating your account...
Your account has been created. Redirecting...
Loading...
This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.